Home » Topics » BioWorld Science

BioWorld Science
RSS

DS-17701585, EP300/CBP inhibitor with efficacy in lung squamous cell carcinoma xenograft

July 8, 2022

Aramchol shows effects in preclinical models of lung and gastrointestinal fibrosis

July 8, 2022

Explant glioblastoma model may allow early precision treatment of patients

July 8, 2022

Novel vaccination strategy using AMP-CpG against EBV infection shows promise in vivo

July 8, 2022

New ROCK-1/2 inhibitors identified at Chiesi Farmaceutici

July 8, 2022

Shanghai Institute of Materia Medica describes thyroid hormone receptor agonists

July 8, 2022

New pantetheinase inhibitors discovered at Shanghai Meiyue Biotech Development

July 8, 2022

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group present SLC9A3 inhibitors

July 8, 2022

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical patents ADCs targeting B7-H3

July 8, 2022

Novel microRNA panel predicts immunotherapy efficacy in NSCLC

July 8, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...